Copertina

Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24‐week, randomized, double‐blind, active‐controlled, phase 3 trial

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Lingding Xie, Jie Han, Zhifeng Cheng, Dexue Liu, Jie Liu, Chunrong Xu, Wenli Sun, Qingju Li, Fang Bian, Wei Zhang, Jinyu Chen, Qian Zhu, Tara K. Thurber, J. Paul Lock, Bo Zhang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Journal of Diabetes
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Efficacy and safety of dapagliflozin add‐on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled study
di: In‐Kyung Jeong, et al.
Pubblicazione: (2024)

A 52‐week efficacy and safety study of enavogliflozin versus dapagliflozin as an add‐on to metformin in patients with type 2 diabetes mellitus: ENHANCE‐M extension study
di: Tae Seo Sohn, et al.
Pubblicazione: (2024)

A multicentre, double‐blind, placebo‐controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add‐on therapy in type 2 diabetic patients treated with metformin and dapagliflozin
di: Soo Lim, et al.
Pubblicazione: (2024)

Efficacy and safety of chiglitazar add‐on to metformin in type 2 diabetes mellitus ( RECAM study)
di: Leili Gao, et al.
Pubblicazione: (2025)

Retagliptin as add‐on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial
di: Lixin Guo, et al.
Pubblicazione: (2024)

Cofrogliptin once every 2 weeks as add‐on therapy to metformin versus daily linagliptin in patients with type 2 diabetes in China: A randomized, double‐blind, non‐inferiority trial
di: Qian Ren, et al.
Pubblicazione: (2024)

Efficacy of adjunctive octenidine hydrochloride as compared to chlorhexidine and placebo as adjuncts to instrumentation in stage I–II periodontitis: A double‐blinded randomized controlled trial
di: Avita Rath, et al.
Pubblicazione: (2024)

Introductory notes on real-enriched categories
di: Zhang, Dexue
Pubblicazione: (2024)

Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, phase 3 trial
di: Leili Gao, et al.
Pubblicazione: (2024)

Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial
di: Da Hea Seo, et al.
Pubblicazione: (2025)

Combination of retagliptin and henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, active‐controlled, phase 3 trial
di: Yao Wang, et al.
Pubblicazione: (2024)

Fotagliptin add‐on therapy to metformin in patients with uncontrolled type 2 diabetes: A randomised, multicentre, double‐blind, placebo‐controlled, phase 3 trial
di: Nan Yu, et al.
Pubblicazione: (2025)

Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add‐on therapy in drug‐naïve patients with type 2 diabetes ( TRIPLE ‐ AXEL study): A multicentre, randomized, 104‐week, open‐label, active‐controlled trial
di: Nam Hoon Kim, et al.
Pubblicazione: (2024)

A Boolean-valued space approach to separation axioms and sobriety of bitopological spaces
di: He, Jing, et al.
Pubblicazione: (2024)

The bounded ideal monad on the category of quasi-metric spaces and its algebras
di: Wang, Kai, et al.
Pubblicazione: (2024)

d-Boolean algebras and their bitopological representation
di: Yang, Hang, et al.
Pubblicazione: (2025)

Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non‐diabetic chronic kidney disease
di: Victor Wasehuus, et al.
Pubblicazione: (2025)

EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes ; randomized, placebo‐controlled, double‐blind, multicentre trial ( CANNA study)
di: Ji Eun Jun, et al.
Pubblicazione: (2025)

Cardiovascular outcomes between dapagliflozin versus empagliflozin in patients with diabetes mellitus
di: Jee‐Heon Kim, et al.
Pubblicazione: (2024)

Efficacy and safety of diacerein monotherapy in adults with obesity: A randomized, double‐blind, placebo‐controlled trial
di: Yingying Xiang, et al.
Pubblicazione: (2024)

Efficacy and safety of imeglimin add‐on to DPP ‐4 inhibitor therapy in Japanese patients with type 2 diabetes mellitus: An interim analysis of the randomised, double‐blind FAMILIAR trial
di: Kohei Kaku, et al.
Pubblicazione: (2025)

Efficacy and safety of intragastric expandable oral capsules in adults with overweight or obesity: A randomized, double‐blind, placebo‐controlled trial
di: Difei Lu, et al.
Pubblicazione: (2024)

Safe and effective pressure of endotracheal tube suctioning based on sputum viscosity grades during artificial airway open suctioning procedures: A double‐blind randomized controlled trial
di: Weiquan Liu, et al.
Pubblicazione: (2024)

Fecal microbiota transplantation against moderate‐to‐severe atopic dermatitis: A randomized, double‐blind controlled explorer trial
di: Xiaochun Liu, et al.
Pubblicazione: (2024)

Topical pravibismane as adjunctive therapy for moderate or severe diabetic foot infections: A phase 1b randomized, multicenter, double‐blind, placebo‐controlled trial
di: Benjamin A. Lipsky, et al.
Pubblicazione: (2024)

Dual add‐on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study
di: Kyung Ah Han, et al.
Pubblicazione: (2024)

Assessing the efficacy and safety of combined glimepiride and metformin therapy in type 2 diabetes mellitus management
di: Sah, Ram Pratap, et al.
Pubblicazione: (2025)

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial
di: Koichi Ikeda, et al.
Pubblicazione: (2025)

Successful management of euglycaemic diabetic ketoacidosis in a bexagliflozin‐treated cat
di: Ingrid Madeleine Preteseille, et al.
Pubblicazione: (2025)

Recent Advances of Carbohydrate‐Based Vaccines Against Acinetobacter baumannii
di: Yufeng Zhang, et al.
Pubblicazione: (2025)

MS-LSTM: Exploring Spatiotemporal Multiscale Representations in Video Prediction Domain
di: Ma, Zhifeng, et al.
Pubblicazione: (2023)

MS-RNN: A Flexible Multi-Scale Framework for Spatiotemporal Predictive Learning
di: Ma, Zhifeng, et al.
Pubblicazione: (2022)

Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52‐week, multicentre, randomized, placebo‐controlled, phase III clinical trial
di: Eun‐Gyoung Hong, et al.
Pubblicazione: (2025)

Efficacy and safety of GW117 tablets in major depressive disorder: a randomised, double‐blind, placebo‐controlled, phase 2 dose‐finding study
di: Yifeng Shen, et al.
Pubblicazione: (2025)

A double‐blind trial of decoded neurofeedback intervention for specific phobias
di: Cody A. Cushing, et al.
Pubblicazione: (2024)

Efficacy and safety of low‐dose atorvastatin plus ezetimibe for primary hypercholesterolemia: A randomized, double‐blind, multicenter phase 3 trial
di: Tae Oh Kim, et al.
Pubblicazione: (2025)

Efficacy and safety of eculizumab in Guillain‐Barré syndrome: A phase 3, multicenter, double‐blind, randomized, placebo‐controlled clinical trial
di: Satoshi Kuwabara, et al.
Pubblicazione: (2024)

Efficacy and safety of donepezil in patients with dementia with Lewy bodies: results from a 12‐week multicentre, randomised, double‐blind, and placebo‐controlled phase IV study
di: Etsuro Mori, et al.
Pubblicazione: (2024)

Effect of transcranial direct current stimulation on postoperative sleep disturbance in older patients undergoing lower limb major arthroplasty: a prospective, double‐blind, pilot, randomised controlled trial
di: Jie Yang, et al.
Pubblicazione: (2024)

Efficacy of different indocyanine green doses in fluorescent laparoscopic cholecystectomy: A prospective, randomized, double‐blind trial
di: Siyu Wang, et al.
Pubblicazione: (2024)